Zosano Pharma Total Revenue

As of the most recent data (March 2022), ZSAN shows a total revenue of $660K. That compares with $480K in the prior-year period — up 36.7% year over year. That is below the Healthcare sector average of $110B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ZSAN's total revenue is now $660K (was $480K) — a 36.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Zosano Pharma is outperforming or lagging.

The Healthcare sector average total revenue is about $110B. Zosano Pharma is at $660K, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how ZSAN stacks up against individual peers as well.

Tracking ZSAN's total revenue over time shows whether Zosano Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $660K That compares with $480K in the prior-year period — up 36.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total revenue page, Stockcircle has Zosano Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total revenue (currently $660K) with ownership activity and broader fundamentals.